Author

Ming-Zhi Zhang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Synergistic Anti‐Tumor Effect of Chidamide and Linperlisib on Natural Killer/T‐Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway

Natural killer/T‐cell lymphoma (NKTCL) is an aggressive lymphoma subtype with limited treatment options, especially for relapsed or refractory patients. Chidamide, a histone deacetylase inhibitor, and linperlisib, a phosphatidylinositol‐3‐kinase (PI3K) inhibitor, have shown promise in treating peripheral T‐cell lymphom...

Wen-Xing Jiang, Zhuang-Zhuang Shi, Zhao-Ming Li et al. · Hematological Oncology · 0 citations

Open access Aug 2026

Association between preoperative diagnosis of small airway disease and postoperative pneumonia in resectable esophageal squamous cell carcinoma patients: a retrospective cohort study

Background Esophageal cancer, specifically esophageal squamous cell carcinoma (ESCC), poses a significant health challenge characterized by a poor prognosis and high mortality rates. Surgical interventions, such as minimally invasive esophagectomy, are the primary treatment approach; however, the occurrence of postoper...

Su-Jie Tang, Cheng Shen, Junjie Shi et al. · PeerJ · 0 citations

Open access Jul 2026

Transcriptomic development of a tumor-associated macrophage ferroptosis-glycolysis prognostic signature in diffuse large B-cell lymphoma

GCLC and SLC1A5 emerged as TAM-related candidate genes that warrant further mechanistic and prospective validation and computationally predicted drug sensitivity and associations between TAMFGS and immune-related transcriptomic estimates and computationally predicted drug sensitivity are identified.

Yingjun Wang, Lai Wei, Jie-Ting Wang et al. · European Journal of Medical... · 0 citations